Menu

Blog

Archive for the ‘biotech/medical’ category: Page 1076

Dec 18, 2021

Siemens Healthineers and Varian present AI ecosystem for cancer care at ASTRO 2021

Posted by in categories: biotech/medical, robotics/AI

In this short video, filmed at ASTRO 2021, Siemens Healthineers’ Gabriel Haras introduces the company’s portfolio of artificial intelligence (AI)-based products. Such technologies support the entire care pathway for cancer patients, from screening and diagnostics to treatment and follow-up, including innovations such as AI-based autocontouring and generation of synthetic CT from an MRI scan for radiotherapy planning.

Next, Varian’s Kevin O’Reilly comments on the combining of Varian and Siemens Healthineers into one united company. He notes that the integration of AI capabilities has increased Varian’s ability to innovate, and will help accelerate its intelligent cancer care strategy: accelerating the path to treatment, increasing global access to care, exploiting data-driven insight and improving personalization.

Dec 18, 2021

Top 5 Edge AI Trends to Watch in 2022

Posted by in categories: biotech/medical, business, internet, robotics/AI

2021 saw massive growth in the demand for edge computing — driven by the pandemic, the need for more efficient business processes, as well as key advances in the Internet of Things, 5G and AI.

In a study published by IBM in May, for example, 94 percent of surveyed executives said their organizations will implement edge computing in the next five years.

Continue reading “Top 5 Edge AI Trends to Watch in 2022” »

Dec 18, 2021

How a new mRNA vaccine could use the body’s immune system to fight cancer

Posted by in category: biotech/medical

German drugmaker BioNTech is enrolling patients in a clinical trial to test its mRNA vaccine for colon cancer relapse.

Dec 18, 2021

N of 1 Extend Lifespan Experiment: Evaluating Progress | Dr Lustgarten Interview Series 3 Ep 2

Posted by in categories: biotech/medical, food, life extension, media & arts

Part 2


In this video Dr. Lustgarten goes into more detail on what he tracks and how he does the analysis of the results. He emphasizes the importance of running your own tests, to not only look at one biomarker but to then combine that marker with other biomarkers, looking for what is optimal for you.

Continue reading “N of 1 Extend Lifespan Experiment: Evaluating Progress | Dr Lustgarten Interview Series 3 Ep 2” »

Dec 18, 2021

Medicine’s first autonomous AI could prevent blindness due to diabetes — if it can reach those most in need

Posted by in categories: biotech/medical, robotics/AI

“How do we use these new innovative technologies to really mitigate disparities in diabetes outcomes?” asked Risa Wolf, a pediatric endocrinologist at Johns Hopkins Hospital.

Dec 18, 2021

Forever Healthy and Buck Institute announce partnership to advance translational research in human rejuvenation

Posted by in categories: biotech/medical, life extension

Karlsruhe, germany and novato, CA, USA

The Forever Healthy Foundation and the Buck Institute for Research on Aging today announced a new partnership to advance early-stage discoveries at the Institute that show promise to reverse physiologic aging in humans. The focus will be on cutting-edge research aimed at the repair of age-related damage at the cellular and molecular level, a hallmark of the aging process. Forever Healthy will commit up to $1 million per year for five years to drive this innovation. The funding aims to advance early-stage research with high translational potential in order to speed up the transition from lab to product.

German entrepreneur and longevity pioneer Michael Greve founded his humanitarian Forever Healthy initiative with the mission of accelerating the development of therapies to impede the aging process and the diseases that accompany it. This mission is in perfect alignment with the Buck Institute, the first independent biomedical facility in the world focused solely on the biology of aging.

Dec 18, 2021

Researchers Teach Human Brain Cells in a Dish to Play “Pong”

Posted by in categories: biotech/medical, cyborgs, education, neuroscience

Scientists have successfully taught a collection of human brain cells in a petri dish how to play the video game “Pong” — kind of.

Researchers at the biotechnology startup Cortical Labs have created “ mini-brains ” consisting of 800,000 to one million living human brain cells in a petri dish, New Scientist reports. The cells are placed on top of a microelectrode array that analyzes the neural activity.

We think it’s fair to call them cyborg brains, Brett Kagan, chief scientific officer at Cortical Labs and research lead of the project, told New Scientist.

Dec 18, 2021

The Mind-Controlled Bionic Arm With a Sense of Touch

Posted by in categories: biotech/medical, cyborgs, transhumanism

In the first episode of Humans+, Motherboard dives into the world of future prosthetics, and the people working on closing the gap between man and machine.

We follow Melissa Loomis, an amputee from Ohio, who had experimental nerve reversal surgery and is going to Johns Hopkins’ Applied Physics Lab to test out its latest Modular Prosthetic Limb, a cutting-edge bionic arm funded in part by DARPA. Neuro-interfacing machinery is a game changer in terms rehabilitating patients, but what possibilities do these advancements open for the future?

Continue reading “The Mind-Controlled Bionic Arm With a Sense of Touch” »

Dec 17, 2021

Russia’s Clandestine Chemical Weapons Programme and the GRU’s Unit 29155

Posted by in categories: biotech/medical, chemistry, military

https://youtube.com/watch?v=Ac9RBmY9Vd0

On October 15, 2020, the European Union imposed sanctions on six senior Russian officials and a leading Russian research institute over the alleged use of a nerve agent from the Novichok family in the poisoning of opposition leader Alexey Navalny. Russia dismissed as baseless the EU’s allegations that it had not complied with its obligations, under the convention it ratified in 1997, to discontinue its chemical weapons program. Russian officials said the country had nothing to do with Navalny’s poisoning and implied that if any party had used nerve agents on him, it would have been Western secret services. Vladimir Putin, who in 2017 had personally watched over the destruction of the last remaining Russian chemical weapons stash, ridiculed the findings of four separate laboratories, confirmed by the OPCW, that a Novichok-type organophosphate poison was identified in Alexey Navalny’s blood.

Two years earlier, in 2018, Russia had dismissed as unfounded allegations that its military intelligence had used Novichok to poison former Russian spy Sergei Skripal and his daughter. Similarly, Russia had then stated that it had no ongoing chemical weapons program and had destroyed all of its prior arsenals; while alluding that UK agencies may have used their own stash of Novichok to poison the Skripals in a false-flag operation.

Continue reading “Russia’s Clandestine Chemical Weapons Programme and the GRU’s Unit 29155” »

Dec 17, 2021

2022 Cyber Security Trends: Ransomware, Extortion, and State Espionage

Posted by in categories: biotech/medical, business, cybercrime/malcode

2021 will be remembered as a significant year for the cyber security industry. With the pandemic accelerating digital transformation, the threat landscape was in constant flux. Major ransomware attacks demonstrated not just their impact on businesses, but wider society too. As we look ahead to 2022, the only constant in our industry is uncertainty in the cyber realm, but here are a few of our predictions for next year, based on trends we’re already seeing emerge.

Ransomware.